These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29522374)

  • 1. Apelin impairs myogenic response to induce diabetic nephropathy in mice.
    Zhang J; Yin J; Wang Y; Li B; Zeng X
    FASEB J; 2018 Aug; 32(8):4315-4327. PubMed ID: 29522374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells.
    Hashimoto T; Kihara M; Ishida J; Imai N; Yoshida S; Toya Y; Fukamizu A; Kitamura H; Umemura S
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1267-72. PubMed ID: 16556853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apelin/APJ system in the regulation of vascular tone: friend or foe?
    Rikitake Y
    J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting effects of the adipokine, apelin, on diabetic nephropathy.
    Zhang BH; Wang W; Wang H; Yin J; Zeng XJ
    PLoS One; 2013; 8(4):e60457. PubMed ID: 23577111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin/APJ system: A critical regulator of vascular smooth muscle cell.
    Luo X; Liu J; Zhou H; Chen L
    J Cell Physiol; 2018 Jul; 233(7):5180-5188. PubMed ID: 29215755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
    Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
    Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin-13 passes through the ADMA-damaged endothelial barrier and acts on vascular smooth muscle cells.
    Wang LY; Zhang DL; Zheng JF; Zhang Y; Zhang QD; Liu WH
    Peptides; 2011 Dec; 32(12):2436-43. PubMed ID: 22001227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities.
    Guo C; Liu Y; Zhao W; Wei S; Zhang X; Wang W; Zeng X
    J Cell Mol Med; 2015 Sep; 19(9):2273-85. PubMed ID: 26103809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes.
    Liu Y; Zhang J; Wang Y; Zeng X
    Cell Death Dis; 2017 Aug; 8(8):e3006. PubMed ID: 28837139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin retards the progression of diabetic nephropathy.
    Day RT; Cavaglieri RC; Feliers D
    Am J Physiol Renal Physiol; 2013 Mar; 304(6):F788-800. PubMed ID: 23303408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelinergic system in the kidney: implications for diabetic kidney disease.
    Müller T; Kalea AZ; Marquez A; Hsieh I; Haque S; Ye M; Wysocki J; Bader M; Batlle D
    Physiol Rep; 2018 Dec; 6(23):e13939. PubMed ID: 30548130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.
    Liu J; Li QX; Wang XJ; Zhang C; Duan YQ; Wang ZY; Zhang Y; Yu X; Li NJ; Sun JP; Yi F
    Cell Death Dis; 2016 Apr; 7(4):e2183. PubMed ID: 27054338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apelin/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction.
    Li B; Yin J; Chang J; Zhang J; Wang Y; Huang H; Wang W; Zeng X
    J Endocrinol; 2021 Apr; 249(1):1-18. PubMed ID: 33504680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.
    Hashimoto T; Kihara M; Imai N; Yoshida S; Shimoyamada H; Yasuzaki H; Ishida J; Toya Y; Kiuchi Y; Hirawa N; Tamura K; Yazawa T; Kitamura H; Fukamizu A; Umemura S
    Am J Pathol; 2007 Nov; 171(5):1705-12. PubMed ID: 17884970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin binding to human APJ receptor leads to biased signaling.
    Kumar P; Ashokan A; Aradhyam GK
    Biochim Biophys Acta; 2016 Dec; 1864(12):1748-1756. PubMed ID: 27671350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants on extracellular loop domains that dictate interaction between β-arrestin and human APJ receptor.
    Ashokan A; Kameswaran M; Aradhyam GK
    FEBS Lett; 2019 Mar; 593(6):634-643. PubMed ID: 30801688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases.
    Cheng J; Luo X; Huang Z; Chen L
    J Cell Physiol; 2019 Aug; 234(8):12149-12160. PubMed ID: 30585633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.
    Dray C; Debard C; Jager J; Disse E; Daviaud D; Martin P; Attané C; Wanecq E; Guigné C; Bost F; Tanti JF; Laville M; Vidal H; Valet P; Castan-Laurell I
    Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1161-9. PubMed ID: 20233941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of APJ mediated β-arrestin signalling improves high-fat diet induced metabolic dysfunction but does not alter cardiac function in mice.
    Li N; Ma X; Ban T; Xu S; Ma Y; Ason B; Hu LA
    Biochem J; 2020 Sep; 477(17):3313-3327. PubMed ID: 32779693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Electroacupuncture on Expression of Apelin-APJ System of Cerebral Vascular Endothelial Cell in Rats with Cerebral Infarction].
    Yang LH; Du YH; Li J
    Zhen Ci Yan Jiu; 2017 Feb; 42(1):9-13. PubMed ID: 29071991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.